AZD5363 in Patients With Advanced Solid Tumors Harboring AKT Mutations
Clinical trial NCT03310541 · COMPLETED
Trial details
- NCT number
- NCT03310541
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-11
- Primary completion
- 2023-05-03
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.